The present findings contribute to a better understanding of the CCN2 biology and reinforce the importance of its role as a driver of renal fibrosis and vascular rarefaction, mainly mediated by the activation of cellular senescence and favoring the AKI-to-CKD transition and renal damage progression. The gene discussed is CCN2; the disease is renal fibrosis.